Dronedarone after Catheter Ablation of Atrial Fibrillation: A New Option in Hybrid Therapy
Felix Gramley, Felix Vogt, Mohammed Natour, Eva Koellensperger & Klaus Kettering · Cardiology and Angiology: An International Journal · 2017
Background and Aim: Catheter ablation has become the therapy of choice in patients with symptomatic, recurrent, drug-refractory atrial fibrillation (AF). However, frequent AF recurrences often necessitate an adjunctive antiarrhythmic drug (AAD) therapy. Dronedarone is a new class...
Open access
Research Article
10.9734/CA/2017/32001